These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5651948)

  • 1. [Character disorders and their treatment by pipamperone].
    Fouks ; Périvier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 2. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].
    Duché DJ; Bourcier G
    Rev Neuropsychiatr Infant; 1969 Mar; 17(3):165-71. PubMed ID: 4389568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of personality and behavior disorders in childhood epilepsy with Neuleptil].
    Nagayama T; Takeshita K; Kurakawa T
    No To Shinkei; 1967 Sep; 19(9):935-40. PubMed ID: 4866508
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the current possibilities of drug therapy of drug therapy of abnormalities of behavior of the character type in infants and children].
    Zucchi M
    Minerva Med; 1970 Oct; 61(82):4542-50. PubMed ID: 5474918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychodynamic and sociodynamic changes produced by methylperidol].
    Leal R
    Actas Luso Esp Neurol Psiquiatr; 1969 Oct; 28(4):299-305. PubMed ID: 5394271
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
    Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
    Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives.
    Daneel AB
    S Afr Med J; 1967 Oct; 41(39):995-8. PubMed ID: 6081157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of character in the evolutive age. (Review and personal considerations)].
    Mastrangelo G
    Osp Psichiatr; 1967; 35(2):365-84. PubMed ID: 4882317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychological approach to psychopharmacologic experimentation. Polycentric controlled study on the action of a new therapeutic agent in adolescents affected with character and personality disturbances].
    Galli PF; Alberti G; Bencini Bariatti MA; Cozzarini M; Micali C
    Clin Ter; 1969 Apr; 49(2):147-65. PubMed ID: 4947949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the treatment of character and behavior disorders by propericiazine as compared with earlier treatments].
    Filipe-Lourenço A; Lécuyer R; Koupernik C
    Rev Neuropsychiatr Infant; 1966; 14(7):617-24. PubMed ID: 4382962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bad character and Neuleptil. Apropos of a Belgian and Luxembourgian clinical experiment (1963-1964)].
    Bobon J; Gernay JM; Collard J; Goffioul F; Breulet M
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):154-62. PubMed ID: 4387055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some results of the use of propericiazine (RP 8909) in the treatment of disorders of conduct and character in children and adolescents].
    Litinschi G; Fehervary E; Ciumăgeanu D
    Neurol Psihiatr Neurochir; 1970; 15(6):493-504. PubMed ID: 4396039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L
    Rev Neuropsychiatr Infant; 1969 Aug; 17(8):557-61. PubMed ID: 4391428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of oligophrenic children and adolescents with propericiazine].
    Dostál T
    Act Nerv Super (Praha); 1968 Oct; 10(3):319. PubMed ID: 4387432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iatrogenic errors in treatment with tranquilizing agents].
    Krynski S
    Pediatr Prat; 1965; 36(5):154-9. PubMed ID: 5845509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.